Home > Journals > Minerva Urology and Nephrology > Past Issues > Minerva Urologica e Nefrologica 2013 June;65(2) > Minerva Urologica e Nefrologica 2013 June;65(2):85-92

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Share

 

  EXPERTS IN STONE DISEASE 

Minerva Urologica e Nefrologica 2013 June;65(2):85-92

Copyright © 2013 EDIZIONI MINERVA MEDICA

language: English

Stents and stone disease

Van Der Merwe A. 1, Van Heerden H. 1, Bonkat G. 2, Heyns C. 1

1 Department Urology, Stellenbosch University Cape Town, South Africa; 2 Department Urology, Basel University Basel, Switzerland


PDF


The use of stents in renal stone disease is relatively new. The main advantage is reduced pressure in the renal collecting system during times of infected obstructed collecting systems, surgery or obstructing stones. As much pain relieve theses stents offer when indicated, equally much morbidity is caused when stent materials interface with the human urothelium in terms of symptoms, perforations and the “forgotten stent”. This review aim to summarize some of the most important considerations when stents are used in stone disease.

top of page